BioXcel Therapeutics operates with a lean, specialized team numbering approximately 30 to 60 full-time employees across its corporate and research operations. Following strategic corporate restructuring, workforce reductions, and cost-containment measures implemented over recent fiscal years, the clinical-stage biopharmaceutical enterprise streamlined its workforce to preserve operational capital for core neuroscience trials.